Marc Belsky - 27 Mar 2025 Form 4 Insider Report for Kezar Life Sciences, Inc. (KZR)

Reporting relationship: Chief Financial Officer
Issuer ticker: KZR
Reported as of: 27 Mar 2025
Net transaction value: $0
SEC form: 4
Accepted by SEC: 01 Apr 2025, 20:41:07 UTC
Prior SEC filing: 05 Mar 2025
Next SEC filing: 11 May 2026
Source filing: View source filing
Reporting owner signature: /s/ Marc Belsky

Key filing fact

Marc Belsky filed Form 4 for Kezar Life Sciences, Inc. (KZR) on 01 Apr 2025.

Key facts

This page summarizes Marc Belsky's Form 4 filing for Kezar Life Sciences, Inc. (KZR).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 01 Apr 2025, 20:41.

Change

Previous filing in this sequence was filed on 05 Mar 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

KZR transaction Derivative

Employee Stock Option (right to buy)

Award

Transaction value: $0
Shares: +4,800
Change %: +67%
Price: $0.000000
Shares after: 12,000
Date: 27 Mar 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 4,800
Exercise price: $6.30
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

On July 11, 2024, the Reporting Person was granted an option to purchase 12,000 shares of common stock that vests on July 11, 2025, pending the achievement of non-financial performance criteria and continuing service through such date. On March 4, 2025, the Company's Compensation Committee (the "Committee") certified that certain of the non-financial performance criteria were achieved for 7,200 shares underlying the option. On March 27, 2025, the Committee certified that certain of the non-financial performance criteria were achieved for the remaining 4,800 shares underlying the option and as such, the entire option will vest on July 11, 2025, provided the Reporting Person continues to provide service through such date.